Clinical Trial

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Name: PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma — clinical trial record (NCT07128290)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PEHRICCA

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this trial is to determine whether the combination of CISGEM and Rilvegostomig during the perioperative period works to improve outcomes of patient undergoing surgery of high-risk of intrahepatic cholangiocarcinoma

Trial Details

NCT Number	NCT07128290
Lead Sponsor	Federation Francophone de Cancerologie Digestive
Conditions	Intrahepatic Cholangiocarcinoma (Icc)
Enrollment	49 participants
Start Date	2025-10-30
Primary Completion	2029-04-30 (estimated)
Study Completion	2029-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-08-17